{
    "address1": "1040 Spring Street",
    "city": "Silver Spring",
    "state": "MD",
    "zip": "20910",
    "country": "United States",
    "phone": "301 608 9292",
    "fax": "301 608 9291",
    "website": "https://www.unither.com",
    "industry": "Biotechnology",
    "sector": "Healthcare",
    "longBusinessSummary": "United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertension (PAH) to diminish symptoms associated with exercise; Tyvaso, an inhaled solution via ultrasonic nebulizer; Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Remunity Pump, a small, lightweight, durable pump and separate controller; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; Unituxin, a monoclonal antibody for treating high-risk neuroblastoma; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. The company also engages in developing RemoPro and Ralinepag for the treatment of PAH; Aurora-GT, a gene therapy product to rebuild the blood vessels in the lungs; and TETON studies, which are the studies of Tyvaso for the treatment of idiopathic pulmonary fibrosis. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was incorporated in 1996 and is headquartered in Silver Spring, Maryland.",
    "fullTimeEmployees": 985,
    "companyOfficers": [
        {
            "maxAge": 1,
            "name": "Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D.",
            "age": 67,
            "title": "Founder, Chairman & CEO",
            "yearBorn": 1955,
            "fiscalYear": 2022,
            "totalPay": 5322204,
            "exercisedValue": 56145352,
            "unexercisedValue": 497331264
        },
        {
            "maxAge": 1,
            "name": "Mr. Michael I. Benkowitz",
            "age": 50,
            "title": "Pres & COO",
            "yearBorn": 1972,
            "fiscalYear": 2022,
            "totalPay": 2828435,
            "exercisedValue": 7832730,
            "unexercisedValue": 90841432
        },
        {
            "maxAge": 1,
            "name": "Mr. James C. Edgemond",
            "age": 54,
            "title": "CFO & Treasurer",
            "yearBorn": 1968,
            "fiscalYear": 2022,
            "totalPay": 2005784,
            "exercisedValue": 1487706,
            "unexercisedValue": 71325464
        },
        {
            "maxAge": 1,
            "name": "Mr. Paul A. Mahon J.D.",
            "age": 58,
            "title": "Exec. VP, Gen. Counsel & Corp. Sec.",
            "yearBorn": 1964,
            "fiscalYear": 2022,
            "totalPay": 2309202,
            "exercisedValue": 13200417,
            "unexercisedValue": 70995872
        },
        {
            "maxAge": 1,
            "name": "Mr. Dewey  Steadman C.F.A.",
            "title": "Head of Investor Relations",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Ms. Holly  Hobson",
            "title": "Associate VP of HR",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Kevin T. Gray",
            "title": "Sr. VP of Strategic Operations & Logistics",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Patrick  Poisson",
            "age": 54,
            "title": "Exec. VP of Technical Operations",
            "yearBorn": 1968,
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Dr. Leigh  Peterson",
            "title": "Sr. VP of Product Devel.",
            "exercisedValue": 0,
            "unexercisedValue": 0
        },
        {
            "maxAge": 1,
            "name": "Mr. Gil  Golden",
            "title": "Sr. VP & Chief Medical Officer",
            "exercisedValue": 0,
            "unexercisedValue": 0
        }
    ],
    "auditRisk": 1,
    "boardRisk": 5,
    "compensationRisk": 3,
    "shareHolderRightsRisk": 3,
    "overallRisk": 2,
    "governanceEpochDate": 1693526400,
    "compensationAsOfEpochDate": 1672444800,
    "maxAge": 86400,
    "priceHint": 2,
    "previousClose": 222.63,
    "open": 223.15,
    "dayLow": 221.81,
    "dayHigh": 225.45,
    "regularMarketPreviousClose": 222.63,
    "regularMarketOpen": 223.15,
    "regularMarketDayLow": 221.81,
    "regularMarketDayHigh": 225.45,
    "payoutRatio": 0.0,
    "beta": 0.62206,
    "trailingPE": 12.612325,
    "forwardPE": 10.751194,
    "volume": 164192,
    "regularMarketVolume": 164192,
    "averageVolume": 335808,
    "averageVolume10days": 209950,
    "averageDailyVolume10Day": 209950,
    "bid": 0.0,
    "ask": 0.0,
    "bidSize": 800,
    "askSize": 800,
    "marketCap": 10565936128,
    "fiftyTwoWeekLow": 201.65,
    "fiftyTwoWeekHigh": 283.09,
    "priceToSalesTrailing12Months": 5.005418,
    "fiftyDayAverage": 231.864,
    "twoHundredDayAverage": 239.3497,
    "trailingAnnualDividendRate": 0.0,
    "trailingAnnualDividendYield": 0.0,
    "currency": "USD",
    "enterpriseValue": 8686945280,
    "profitMargins": 0.41286,
    "floatShares": 43208066,
    "sharesOutstanding": 46932600,
    "sharesShort": 1889328,
    "sharesShortPriorMonth": 992626,
    "sharesShortPreviousMonthDate": 1689292800,
    "dateShortInterest": 1692057600,
    "sharesPercentSharesOut": 0.0403,
    "heldPercentInsiders": 0.0177,
    "heldPercentInstitutions": 0.99973,
    "shortRatio": 4.98,
    "shortPercentOfFloat": 0.0456,
    "bookValue": 115.341,
    "priceToBook": 1.9518645,
    "lastFiscalYearEnd": 1672444800,
    "nextFiscalYearEnd": 1703980800,
    "mostRecentQuarter": 1688083200,
    "earningsQuarterlyGrowth": 1.234,
    "netIncomeToCommon": 871500032,
    "trailingEps": 17.85,
    "forwardEps": 20.94,
    "pegRatio": 1.19,
    "lastSplitFactor": "2:1",
    "lastSplitDate": 1253664000,
    "enterpriseToRevenue": 4.115,
    "enterpriseToEbitda": 7.558,
    "exchange": "NMS",
    "quoteType": "EQUITY",
    "symbol": "UTHR",
    "underlyingSymbol": "UTHR",
    "shortName": "United Therapeutics Corporation",
    "longName": "United Therapeutics Corporation",
    "firstTradeDateEpochUtc": 929626200,
    "timeZoneFullName": "America/New_York",
    "timeZoneShortName": "EDT",
    "gmtOffSetMilliseconds": -14400000,
    "currentPrice": 225.13,
    "targetHighPrice": 375.0,
    "targetLowPrice": 170.0,
    "targetMeanPrice": 284.6,
    "targetMedianPrice": 303.5,
    "recommendationMean": 2.0,
    "recommendationKey": "buy",
    "numberOfAnalystOpinions": 10,
    "totalCash": 2679000064,
    "totalCashPerShare": 57.082,
    "ebitda": 1149299968,
    "totalDebt": 800000000,
    "quickRatio": 7.971,
    "currentRatio": 8.678,
    "totalRevenue": 2110899968,
    "debtToEquity": 14.785,
    "revenuePerShare": 45.74,
    "returnOnAssets": 0.11217,
    "returnOnEquity": 0.17915002,
    "grossProfits": 1784700000,
    "freeCashflow": 509612512,
    "operatingCashflow": 867900032,
    "earningsGrowth": 1.174,
    "revenueGrowth": 0.278,
    "grossMargins": 0.89938,
    "ebitdaMargins": 0.54446,
    "operatingMargins": 0.51967996,
    "financialCurrency": "USD",
    "trailingPegRatio": 1.78,
    "parent_etfs": [
        "AGNG"
    ]
}